2w3 min read
Medical Article
Introduction Radiotracers targeting the prostate-specific membrane antigen (PSMA) are widely used in clinical practice for positron emission tomography (PET) imaging of prostate cancer (1). PSMA is expressed as a type II transmembrane protein on the surface of prostate cancer cells, with moderate to low expression in healthy tissues and the highest

Gallium-68 PSMA-11 PET Imaging in Prostate Cancer: Mechanism of Action and Clinical Overview
Similar Content

Complicated case of Osteoarthritis
1850 Reached2 Comments3 Likes

CT Angiography of Spontaneous Coronary Artery Dissection
4208 Reached15 Comments13 Likes

Cardiac Amyloidosis Mimicking Severe Aortic Valve Stenosis
6672 Reached15 Comments15 Likes

Safe Ramadan Practices during COVID-19 - WHO Guidance
6556 Reached8 Comments3 Likes

How Physicians Should Manage Stress?
35340 Reached151 Comments202 Likes
